| Ginger Leigh Teasley, MA, LMFT | |
|
42104 N Venture Dr, Buildng D, Ste 102-106, Unit 3, Anthem, AZ 85086-3823 | |
| (623) 853-5151 | |
| Not Available |
| Full Name | Ginger Leigh Teasley |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 42104 N Venture Dr, Anthem, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174774475 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | LMFT-10274 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ginger Leigh Teasley, MA, LMFT 42025 N Club Pointe Dr, Anthem, AZ 85086-1966 Ph: (623) 551-9161 | Ginger Leigh Teasley, MA, LMFT 42104 N Venture Dr, Buildng D, Ste 102-106, Unit 3, Anthem, AZ 85086-3823 Ph: (623) 853-5151 |
News Archive
Cerulean Pharma Inc., a leader in designing and developing tumor-targeted nanopharmaceuticals, today announced the dosing of the first patients with CRLX101 in a randomized, controlled non-small cell lung cancer (NSCLC) Phase 2 clinical trial.
A new study reveals an association between prenatal exposure to environmental pollutants and elevated body mass index (BMI) during the first three years of life, as reported in the January 2009 issue of the peer-reviewed journal Environmental Health Perspectives (EHP).
SDIX, a leading provider of biotechnology-based products and services for a broad range of life science, biotechnology, diagnostic and food safety applications, and BD Diagnostics, a segment of BD, a leading global medical technology company, today announced the signing of a comprehensive agreement whereby the two companies will collaborate in the development of a microbiology detection solution.
The Alzheimer's Drug Discovery Foundation announced today a $900,000 grant to AgeneBio, a pharmaceutical company developing innovative therapies for neurologic and psychiatric diseases. The grant will support the initiation of an FDA-registered Phase 3 clinical trial of AGB101, a new therapeutic treatment for amnestic mild cognitive impairment (aMCI).
As part of the 60th National Mental Health Week, which runs from May 1 to 7, 2011, the Mental Illness Foundation invites Quebecers to take action and be attentive to loved ones coping with a mental illness and underlines that the search for good mental health is one of the protective factors in preventing mental illness.
› Verified 4 days ago
Ludmela Lola Leshney, MFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 41408 N Congressional Dr, Anthem, AZ 85086 Phone: 623-826-9237 Fax: 623-551-5777 | |
Julie Caldwell, MS LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 39905 N Gavilan Peak Pkwy, Anthem, AZ 85086 Phone: 602-791-0894 |